R1
Core Ring
Subscription Revenue
The foundation. Recurring SaaS revenue from tiered intelligence delivery.
Subscription Tiers
- Signal – $229/mo
- Shield – $349/mo
- Command – $649/mo
- Enterprise – Custom
- Sovereign – Custom
Execution Model
Direct sales from walkthrough → dossier → deployment call pipeline. Upsell from Signal to higher tiers as organizations see compounding value.
Why It Works
Unlike consulting (project-based), intelligence compounds. Cancellation means losing institutional memory.
Revenue Target
Y1: $375K → Y5: $12M+ ARR
R2
Network Ring
Partner Referral Revenue
When the intelligence engine detects a client need that matches a partner specialty, it routes a warm, context-rich introduction.
Partner Categories
Insurance specialists, regulatory consultants, BD/licensing advisors, IP attorneys, clinical trial consultants, market access strategists.
Execution Model
Build opt-in partner directory. Engine detects need from client signals. Referral fee on successful engagement (15-25% of first engagement or ongoing rev-share).
Why It Works
Zero incremental CAC. Partners get pre-qualified leads they can't access elsewhere. Clients get vetted experts at the exact moment of need.
Revenue Target
Y2: $180K → Y5: $2.4M
R3
Network Ring
Enterprise Expansion
Single-seat clients expand to multi-seat, multi-department, and eventually white-label deployments.
Expansion Path
Land with one champion (usually BD or strategy lead), expand to executive team, then research, then regulatory. Each department gets role-specific views. Enterprise contracts replace individual subscriptions.
Why It Works
Once institutional memory accumulates, switching costs become enormous. The system knows their competitors, their pipeline, their regulatory timeline.
Revenue Target
Y2: $500K → Y5: $8M
R4
Scale Ring
Aggregated Market Intelligence
Anonymized, aggregated intelligence reports sold to the broader industry. Sector-level insights derived from the collective intelligence of all client deployments.
Execution Model
Once sufficient client base exists (50+ organizations), aggregate anonymized signals into quarterly sector reports. Sell to investment banks, consulting firms, government agencies.
Why It Works
Data is already being processed. Aggregation and anonymization create a new product at near-zero marginal cost.
Revenue Target
Y3: $200K → Y5: $1.5M
R5
Core Ring
Training & Certification
AI literacy and intelligence operations courses for biopharma professionals.
Curriculum
Intelligence-driven decision-making, AI literacy for regulated environments, and AimwellBio platform mastery. Certification becomes industry-recognized.
Why It Works
Positions AimwellBio as the authority on biopharma intelligence. Trained users become advocates and buyers.
Revenue Target
Y2: $120K → Y5: $800K
R6
Scale Ring
Sovereign & Government Contracts
National health agencies, government pharmaceutical organizations, and sovereign wealth-backed health initiatives.
Execution Model
Purpose-built deployments with data sovereignty (in-country hosting), custom compliance frameworks, and dedicated support. Entry through existing enterprise relationships or direct government procurement.
Why It Works
Governments spend billions on health intelligence with fragmented, outdated tools. A verified, sovereign-deployable intelligence system fills an enormous gap.
Revenue Target
Y3: $500K → Y5: $3M
R7
Scale Ring
Consulting Marketplace
Expert network directory where partners are surfaced contextually to clients who need them.
Execution Model
Partners opt in and set availability. Engine matches client needs to partner expertise. Platform facilitates introduction. Revenue share on successful engagements.
Why It Works
Marketplace effect — more partners attract more clients, more clients attract more partners. AimwellBio captures margin on every transaction.
Revenue Target
Y3: $100K → Y5: $1.1M